WE WANT THE 78!!! LOL 

I see the YINN 130min HP shows FLAT? 

IWM engulfer, will take home TZA

I'd expect UUP and/or BABA to be new longs today on the KISS system

Bravo Arun https://x.com/FusionptCapital/status/1944890020864909482

$NUKZ 

BULL Aug1 $13c lit up, tight coil. too 

_{VKTX base 
https://schrts.co/BRXyfeWM}

thanks as always for the detailed analysis. The live chart function isnt working for me, not sure if it affected anyone else. 

KTOS new ath on that news 

BTC pushing the crypto names like HIVE! LFG 

HIVE .....ready for launch 

MTCH daily breakout 

boom for REMX!

this plays into CLSK, HIVE etc 

Added Oct $13c for $1.09
https://schrts.co/ARjBaTDf

Hammering off trendline....granted 2hrs left 

big upside possible as mentioned in analyst note, def not "trash" 

Teladoc (TDOC)is a left-for-dead telemedicine company that spent significant capital during the “boom” years investing in a platform that now has significant competitive advantages TDOC is using AI to reduce costs and reinvesting into expanded offerings, such as their recent acquisition of Catapult Health, and I think the business is positioned to accelerate materially from here.  – unlike many “live the dream” healthcare and technology stocks from the 2021-era – TDOC is actually profitable.  The acquisition of Catapult Health strengthens Teladoc's position in the AI-enabled healthcare landscape by significantly furthering its Integrated Care game plan.  Through VirtualCheckup's sophisticated at-home diagnostic testing and virtual care platform, Teladoc gains access to rich longitudinal health data from over three million covered lives, with nearly 50% of patients having identifiable chronic conditions – precisely the type of structured healthcare data that AI systems can leverage for personalized care recommendations. The design element is enhanced through Catapult's highly engaging user experience (demonstrated by an 81+ NPS) and proven clinical outcomes, including a 77% reduction in crisis-level hypertension and 56% improvement in medication compliance, while the distribution advantage is amplified by cross-selling opportunities across Teladoc's 93.9 million US integrated care members. This consolidation of preventative care capabilities positions Teladoc to better harness AI for proactive health interventions, as evidenced by its ability to identify pre-diabetes in 28% of members for the first time, making it a more compelling play on AI enablementin healthcare while delivering tangible ROI and $1,400 in verified cost savings per member over three years.

ICLN actually making turn up lately, higher lows.